Morgan Stanley Maintains Ascendis Pharma A (ASND) Equal-Weight Recommendation
29/4 13:39
Fintel reports that on April 28, 2023, Morgan Stanley maintained coverage of Ascendis Pharma A (NASDAQ:ASND) with a Equal-Weight recommendation....
|
|
|
29/4 13:39
Fintel reports that on April 28, 2023, Morgan Stanley maintained coverage of Ascendis Pharma A (NASDAQ:ASND) with a Equal-Weight recommendation....